| # | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
|---|
Wells Fargo analyst Elyse Greenspan maintains MetLife (NYSE:MET) with a Overweight and lowers the price target from $96 to $92.
UBS analyst Brian Meredith maintains MetLife (NYSE:MET) with a Buy and lowers the price target from $96 to $95.
MetLife (NYSE:MET) reported quarterly earnings of $2.37 per share which beat the analyst consensus estimate of $2.32 by 2.2 per...
Wall Street bounced back Wednesday after Tuesday's sharp selloff in AI-driven stocks, as investors bought the dip amid soli...
SoftBank CEO Masayoshi Son's 2024 prediction that Nvidia was "undervalued" has proven accurate as Jensen Huang'...